Start here if you're new
what it is
Mativ makes specialty materials for filtration, healthcare, packaging, labels, and tapes.
how it gets paid
Last year Mativ made $2.0B in revenue. Filtration media & components was the main engine at $0.65B, or 32% of sales.
why it's growing
Revenue grew 0.3% last year. The -$8.04 EPS number mattered because it is far worse than the trailing -$0.24 and shows how lumpy the business is.
what just happened
Mativ brought in $1.5B of revenue, but EPS was -$8.04.
At a glance
C+ balance sheet — struggling to keep the lights on
25/100 earnings predictability — expect surprises
4.5% dividend yield — cash in your pocket every quarter
1.3% return on capital — nothing to write home about
-$0.90 fy2024 eps est
xvary composite: 40/100 — below average
What they do
Mativ makes specialty materials for filtration, healthcare, packaging, labels, and tapes.
Mativ sells materials you do not replace casually. It runs through 2 operating segments and 5,100 employees, so it can serve filtration, healthcare, and packaging at scale. If your product needs a precise material, switching vendors is pain, not a purchase.
How they make money
$2.0B
annual revenue · their business grew +0.3% last year
Filtration media & components
$0.65B
Advanced films & converting
$0.35B
Extruded mesh products
$0.15B
Tapes & labels
$0.50B
Specialty paper, packaging & healthcare
$0.35B
The products that matter
industrial filtration materials
Filtration Media
part of $1.1B segment · -2%
it sits inside the $1.1B filtration and performance materials segment, which fell 2% last year, so demand depends on industrial activity more than product magic.
largest segment
backing for labels and tapes
Release Liners
part of $0.9B segment · +3%
release liners live inside the $0.9B advanced technical materials segment, which grew 3% last year. steady helps, but it does not offset a weak balance sheet on its own.
steady, not enough
engineered specialty papers
Engineered Papers
within $2B revenue base
these products are part of a $2B annual revenue platform that still produced only 1.3% return on capital. scale exists. pricing power is the part still on trial.
returns problem
Key numbers
$2.0B
annual revenue
Revenue means sales. Mativ brought in $2.0B, so every margin point matters.
19.3%
operating margin
Operating margin means profit before interest and taxes. Mativ lost 19.3 cents on every sales dollar.
$1.1B
long-term debt
Debt means borrowed money. This is 69% of capital, so mistakes get expensive fast.
4.5%
dividend yield
Yield means cash payout versus share price. You get paid, but past dividend growth was -9.5%.
Financial health
C+
strength
- balance sheet grade C+ — weak — may struggle to fund operations
- risk rank 5 — safer than 5% of stocks
- price stability 15 / 100
- long-term debt $1.1B (69% of capital)
C+ — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for MATV right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Mativ brought in $1.5B of revenue, but EPS was -$8.04.
Revenue was up 197% from the prior year quarter, but gross margin was only 18.1% and the company still lost money. Annual revenue was $2.0B, up 0.3% vs. prior year.
$1.5B
revenue
-$8.04
eps
18.1%
gross margin
the number that mattered
The -$8.04 EPS number mattered because it is far worse than the trailing -$0.24 and shows how lumpy the business is.
source: EDGAR and Yahoo Finance consensus
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
The #1 risk here is balance-sheet pressure from $1.1B of debt. That is the lens every other risk now passes through.
med
debt outruns the equity cushion
Long-term debt is $1.1B, or 69% of capital, against a market cap of about $484M. That is a small equity base carrying a very real financing burden.
If operating performance slips, lenders gain leverage fast and shareholders get less room for error.
med
the dividend competes with repair work
A 4.5% dividend yield sounds helpful, but it also represents cash leaving a company analysts expect to lose $0.90 per share this year.
If cash gets tighter, management may have to choose between defending the payout and strengthening the balance sheet.
med
the business is not earning enough yet
Return on capital is 1.3% on a $2B revenue business. One segment fell 2% last year and the other grew only 3%.
Low returns leave little buffer. If volumes weaken or pricing slips, equity holders feel it quickly.
$1.1B of debt plus a 1.3% return on capital means even modest operating misses can matter a lot more than you want in a $484M equity.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
may 6, 2026 earnings call
This is the next scheduled proof point. You want to hear how much of the $15M–$20M savings program is already flowing through.
balance sheet
debt service versus cash generation
With $1.1B of long-term debt, cash generation matters more than narrative. If the business stumbles, financial flexibility gets tight quickly.
returns
return on capital moving off 1.3%
This is the quiet part. If returns stay pinned near 1.3%, the turnaround is still mostly cosmetic.
segment trend
whether the 3% growth business can stay positive
Advanced Technical Materials grew 3% last year while the larger segment fell 2%. You need the healthier side of the portfolio to keep holding up.
Analyst rankings
earnings predictability
25 / 100
In human-speak: analysts do not view these quarterly numbers as steady, so surprises are part of the package.
balance sheet grade
C+
That grade translates to a balance sheet you monitor, not one you forget about.
risk rank
5
A rank of 5 means it is safer than only about 5% of stocks in the dataset. That is the opposite of a defensive profile.
source: institutional data
Institutional activity
institutional ownership data for MATV is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$13
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive